Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.

[1]  W. Wiersinga,et al.  Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5'-monophosphate- and iodine-independent mechanism. , 2006, Endocrinology.

[2]  L. Fried,et al.  Thyroid status, cardiovascular risk, and mortality in older adults. , 2006, JAMA.

[3]  Peter O'Leary,et al.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. , 2005, Archives of internal medicine.

[4]  E. Vittinghoff,et al.  Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. , 2005, Archives of internal medicine.

[5]  D. Reda,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[6]  Irwin Klein,et al.  Hypothyroidism as a risk factor for cardiovascular disease , 2004, Endocrine.

[7]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[8]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[9]  L. Braverman,et al.  The effects of amiodarone on the thyroid. , 2001, Endocrine reviews.

[10]  A. Pinchera,et al.  Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. , 1994, Archives of internal medicine.

[11]  W. Wiersinga,et al.  Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. , 1991, The American journal of medicine.

[12]  H. Griffiths,et al.  Amiodarone and the thyroid. , 1989, Clinical chemistry.

[13]  K. Nademanee,et al.  Amiodarone and thyroid function. , 1989, Progress in cardiovascular diseases.

[14]  M. Gammage,et al.  AMIODARONE AND THYROID HORMONE EFFECTS ON ANTERIOR PITUITARY HORMONE GENE EXPRESSION , 1987, Clinical endocrinology.

[15]  A. Pinchera,et al.  AMIODARONE IODINE‐INDUCED HYPOTHYROIDISM: RISK FACTORS AND FOLLOW‐UP IN 28 CASES , 1987, Clinical endocrinology.

[16]  K. Nademanee,et al.  Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias. , 1986, The American journal of cardiology.

[17]  W. Wiersinga,et al.  Amiodarone and thyroid hormone metabolism. , 1986, Postgraduate medical journal.

[18]  A. Pinchera,et al.  IS HUMORAL THYROID AUTOIMMUNITY RELEVANT IN AMIODARONE IODINE‐INDUCED THYROTOXICOSTS (AIIT)? , 1986, Clinical endocrinology.

[19]  K. Nademanee,et al.  Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. , 1986, Acta endocrinologica.

[20]  C. Haffajee,et al.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. , 1984, Annals of internal medicine.

[21]  H. Perrild,et al.  DIFFERENT EFFECTS OF PROPRANOLOL, ALPRENOLOL, SOTALOL, ATENOLOL AND METOPROLOL ON SERUM T3 AND SERUM rT3 IN HYPERTHYROIDISM , 1983, Clinical endocrinology.

[22]  K. Nademanee,et al.  Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. , 1981, The Journal of clinical endocrinology and metabolism.

[23]  J. Wennström,et al.  Control of thyrotoxicosis with sotalol. , 1976, Annals of clinical research.

[24]  K. Harjai,et al.  Effects of Amiodarone on Thyroid Function , 1997, Annals of Internal Medicine.

[25]  S. Albert,et al.  Thyroid dysfunction during chronic amiodarone therapy. , 1987, Journal of the American College of Cardiology.